• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关自然杀伤细胞的 DNA 甲基化特征与自功能化纳米传感器相结合,实现结直肠癌的诊断。

DNA Methylation Signatures of Tumor-Associated Natural Killer Cells with Self-Functionalized Nanosensor Enable Colorectal Cancer Diagnosis.

机构信息

Institute for Biomedical Engineering, Science and Technology (I BEST), Partnership between Toronto Metropolitan University and St. Michael's Hospital, Toronto, Ontario M5B 1W8, Canada.

Ultrashort Laser Nanomanufacturing Research Facility, Faculty of Engineering and Architectural Sciences, Toronto Metropolitan University, 350 Victoria Street, Toronto, Ontario M5B 2K3, Canada.

出版信息

Nano Lett. 2023 May 24;23(10):4142-4151. doi: 10.1021/acs.nanolett.2c04914. Epub 2023 May 3.

DOI:10.1021/acs.nanolett.2c04914
PMID:37134017
Abstract

Natural killer (NK) cells undergo multiple DNA genomic alterations, especially methylation-based modifications that affect activation and function. Several epigenetic modifier markers have been targeted for immunotherapy to date, but the possibility of cancer diagnosis using NK cell's DNA has been overlooked. Here, we investigated the potential use of NK cell DNA genome modifications as markers for the diagnosis of colorectal cancer (CRC) and validated their efficacy in CRC patients. Using Raman spectroscopy as the detection methodology, we identified CRC-specific methylation signatures by comparing CRC-interacted NK cells to healthy circulating NK cells. Subsequently, we identified methylation-dependent alterations in these NK cell populations. These markers were then utilized by a machine learning algorithm to develop a diagnostic model with predictive capabilities. The diagnostic prediction model accurately differentiated CRC patients from normal controls. Our findings demonstrated the utility of NK DNA markers in the diagnosis of CRC.

摘要

自然杀伤 (NK) 细胞经历多种 DNA 基因组改变,特别是影响激活和功能的基于甲基化的修饰。迄今为止,已经针对几种表观遗传修饰标志物进行了免疫治疗,但使用 NK 细胞 DNA 进行癌症诊断的可能性被忽视了。在这里,我们研究了 NK 细胞 DNA 基因组修饰作为结直肠癌 (CRC) 诊断标志物的潜力,并在 CRC 患者中验证了其疗效。使用拉曼光谱作为检测方法,我们通过比较与 CRC 相互作用的 NK 细胞与健康循环 NK 细胞,确定了 CRC 特异性甲基化特征。随后,我们确定了这些 NK 细胞群体中依赖于甲基化的改变。然后,机器学习算法利用这些标记物开发了具有预测能力的诊断模型。该诊断预测模型能够准确地区分 CRC 患者和正常对照者。我们的研究结果表明,NK DNA 标志物在 CRC 的诊断中有一定的应用价值。

相似文献

1
DNA Methylation Signatures of Tumor-Associated Natural Killer Cells with Self-Functionalized Nanosensor Enable Colorectal Cancer Diagnosis.肿瘤相关自然杀伤细胞的 DNA 甲基化特征与自功能化纳米传感器相结合,实现结直肠癌的诊断。
Nano Lett. 2023 May 24;23(10):4142-4151. doi: 10.1021/acs.nanolett.2c04914. Epub 2023 May 3.
2
Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.循环肿瘤 DNA 甲基化谱可实现结直肠癌的早期诊断、预后预测和筛查。
Sci Transl Med. 2020 Jan 1;12(524). doi: 10.1126/scitranslmed.aax7533.
3
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.新型 DNA 甲基化生物标志物具有高灵敏度和特异性,可用于基于血液的结直肠癌检测——一项临床生物标志物发现和验证研究。
Clin Epigenetics. 2019 Nov 14;11(1):158. doi: 10.1186/s13148-019-0757-3.
4
A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.基于粪便 DNA 的甲基化生物标志物在结直肠癌及其前体——结直肠腺瘤中的系统评价和定量评估。
Mutat Res Rev Mutat Res. 2019 Jan-Mar;779:45-57. doi: 10.1016/j.mrrev.2019.01.003. Epub 2019 Jan 16.
5
Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.NPY、PENK 和 WIF1 的异常甲基化作为一种有前途的基于血液的结直肠癌诊断标志物。
BMC Cancer. 2013 Dec 1;13:566. doi: 10.1186/1471-2407-13-566.
6
Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.具有正反馈回路的行走路径揭示了结直肠癌的 DNA 甲基化生物标志物。
BMC Bioinformatics. 2019 Apr 18;20(Suppl 4):119. doi: 10.1186/s12859-019-2687-7.
7
Accumulation of aberrant DNA methylation during colorectal cancer development.在结直肠癌发生过程中异常DNA甲基化的积累。
World J Gastroenterol. 2014 Jan 28;20(4):978-87. doi: 10.3748/wjg.v20.i4.978.
8
Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review.粪便 DNA 甲基化标志物用于检测结直肠癌及其前体的分期:系统评价。
Clin Epigenetics. 2020 Aug 10;12(1):122. doi: 10.1186/s13148-020-00904-7.
9
Feasibility of quantifying methylation in stool DNA for early detection of colorectal cancer.检测粪便 DNA 甲基化用于结直肠癌早期检测的可行性研究。
Clin Epigenetics. 2017 Dec 4;9:126. doi: 10.1186/s13148-017-0426-3. eCollection 2017.
10
DNA Methylation-Based Testing in Peripheral Blood Mononuclear Cells Enables Accurate and Early Detection of Colorectal Cancer.基于外周血单核细胞 DNA 甲基化的检测可实现结直肠癌的准确、早期检测。
Cancer Res. 2023 Nov 1;83(21):3636-3649. doi: 10.1158/0008-5472.CAN-22-3402.

引用本文的文献

1
Multifaceted Applications of Nanomaterials in Colorectal Cancer Management: Screening, Diagnostics, and Therapeutics.纳米材料在结直肠癌管理中的多方面应用:筛查、诊断与治疗
Int J Nanomedicine. 2025 Jun 10;20:7271-7294. doi: 10.2147/IJN.S520616. eCollection 2025.
2
Plasmonic Molecular Entrapment for Label-Free Methylated DNA Detection and Machine-Learning Assisted Quantification.用于无标记甲基化DNA检测和机器学习辅助定量的等离子体分子捕获
Adv Sci (Weinh). 2025 May 8:e2503257. doi: 10.1002/advs.202503257.